Abstract
Among gastro-intestinal cancers, pancreatic cancer is the fourth leading cause of cancer-related death mainly due to late diagnosis. Although there is significant improvement in chemotherapy regimen but still five year survival rate is maximum 6%. Resistance offered by cancer stem cells towards the chemotherapeutic drug might be one solid reason behind this. Cancer stem cells (CSC), a subset of the heterogeneous cell population of a tumor are self-renewable and can differentiate into all types of cancer cells. Inhibition of CSC activity might be a good approach in treatment of cancer. Anti-cancer activities of several naturally occurring phytochemicals are well established. Plethora of evidences supports the protective role of phytochemicals in suppressing CSC acivity. Here in this review an attempt has been made to summarize the activity of phytochemicals like curcumin, resveratrol, quercetin, catechin etc. towards inhibiting CSCs in pancreatic cancer.
Keywords: Stem cell, pancreatic cancer, resistance, phytochemicals, curcumin, resveratrol, quercetin.
Graphical Abstract
Current Chemical Biology
Title:Phytochemicals and Cancer Stem Cells: A Pancreatic Cancer Overview
Volume: 10 Issue: 2
Author(s): Suvroma Gupta and Dipankar Pramanik
Affiliation:
Keywords: Stem cell, pancreatic cancer, resistance, phytochemicals, curcumin, resveratrol, quercetin.
Abstract: Among gastro-intestinal cancers, pancreatic cancer is the fourth leading cause of cancer-related death mainly due to late diagnosis. Although there is significant improvement in chemotherapy regimen but still five year survival rate is maximum 6%. Resistance offered by cancer stem cells towards the chemotherapeutic drug might be one solid reason behind this. Cancer stem cells (CSC), a subset of the heterogeneous cell population of a tumor are self-renewable and can differentiate into all types of cancer cells. Inhibition of CSC activity might be a good approach in treatment of cancer. Anti-cancer activities of several naturally occurring phytochemicals are well established. Plethora of evidences supports the protective role of phytochemicals in suppressing CSC acivity. Here in this review an attempt has been made to summarize the activity of phytochemicals like curcumin, resveratrol, quercetin, catechin etc. towards inhibiting CSCs in pancreatic cancer.
Export Options
About this article
Cite this article as:
Gupta Suvroma and Pramanik Dipankar, Phytochemicals and Cancer Stem Cells: A Pancreatic Cancer Overview, Current Chemical Biology 2016; 10 (2) . https://dx.doi.org/10.2174/2212796810666160419152309
DOI https://dx.doi.org/10.2174/2212796810666160419152309 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aldose Reductase Enzyme and its Implication to Major Health Problems of the 21st Century
Current Medicinal Chemistry Curcumin, Hesperidin, and Rutin Selectively Interfere with Apoptosis Signaling and Attenuate Streptozotocin-Induced Oxidative Stress- Mediated Hyperglycemia
Current Neurovascular Research Smoking and Cardiovascular System: Cellular Features of the Damage
Current Pharmaceutical Design Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
Current Drug Targets FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus
Current Neurovascular Research CD36 and Intestinal Fatty Acid Absorption
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Oncolytic Coxsackievirus and the Mechanisms of its Effects on Cancer: A Narrative Review
Current Cancer Therapy Reviews Novel Strategies for the Management of Acute Decompensated Heart Failure
Current Cardiology Reviews Chromogranin-A: A Multifaceted Cardiovascular Role in Health and Disease
Current Medicinal Chemistry Methods for Identifying Cardiovascular Agents: A Review
Recent Patents on Cardiovascular Drug Discovery Avian Genomes: Important Resources for Understanding Vertebrate Biology
Current Genomics Mesenchymal Stem Cell Therapy for Acetaminophen-related Liver Injury: A Systematic Review and Meta-analysis of Experimental Studies <i>In Vivo</i>
Current Stem Cell Research & Therapy Cardiac Chamber Volumetric Assessment Using 3D Ultrasound - A Review
Current Pharmaceutical Design The Anti-fibrotic Hormone Relaxin is not Reno-protective, Despite Being Active, in an Experimental Model of Type 1 Diabetes
Protein & Peptide Letters Treatment of the Cheyne-Stokes Breathing Pattern in Patients with Congestive Heart Failure: State of the Art
Current Respiratory Medicine Reviews Gene Patents in the Primary Prevention of Vascular Diseases
Recent Patents on DNA & Gene Sequences Neuregulin1 as Novel Therapy for Heart Failure
Current Pharmaceutical Design Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting Molecules
Current Medicinal Chemistry Editorial (Thematic Issue: Frontiers in Atherosclerosis, Heart Disease and Diabetes)
Cardiovascular & Hematological Disorders-Drug Targets Editorial (Thematic Issue: Current Topics in Pharmacogenomics)
Recent Patents on Biotechnology